Lensar (LNSR) EBIT Margin Growth (3y) (2022 - 2026)
Lensar (LNSR) EBIT Margin Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.06 Bn | 175.76 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 128.66 Bn | 125.78 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 48.29 Bn | 44.61 Bn | 1.29 Bn | -283.00 |
| 6 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | -184.00 |
| 7 | Dexcom | 28.29 Bn | 27.18 Bn | 750.30 Mn | 1,505.00 |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 2,016.00 |
| 10 | Lensar | 66.89 Mn | 55.79 Mn | 6.38 Mn | 6,952.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,952.00 |
| Dec 31, 2025 | -2,283.00 |
| Sep 30, 2025 | -673.00 |
| Jun 30, 2025 | 5,147.00 |
| Mar 31, 2025 | 3,066.00 |
| Dec 31, 2024 | 2,084.00 |
| Sep 30, 2024 | 7,770.00 |
| Jun 30, 2024 | 1,509.00 |
| Mar 31, 2024 | -89,510.00 |
| Dec 31, 2023 | 11,803.00 |
| Sep 30, 2023 | 5,294.00 |
| Jun 30, 2023 | 5,618.00 |
| Mar 31, 2023 | -38.00 |
| Dec 31, 2022 | -446.00 |
| Sep 30, 2022 | 1,345.00 |